Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02664142
Other study ID # FNO-KARIM-3
Secondary ID
Status Completed
Phase N/A
First received January 18, 2016
Last updated March 22, 2018
Start date June 2015
Est. completion date November 2017

Study information

Verified date March 2018
Source University Hospital Ostrava
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

General anaesthesia (GA) is, according to many definitions, the greatest gift presented to the medical art (S. B. Nuland). One of the aims of GA is to achieve the optimal depth of anaesthesia and rapid emergence from general anaesthesia. In order to achieve this goal, it is necessary to observe the clinical condition of the patient, and at the same time monitor the patient's overall condition. With the currently available options of GA management (e.g. use of intravenous anaesthetics, strong analgesics and modern volatile anaesthetics, in combination with various methods of topical anaesthesia) the importance of methods measuring the depth of GA increases. The depth of GA may be defined as a continuous progressive decreasing of the central nervous system, together with a decreased reactivity to stimuli. In the course of GA, perioperative awareness is detected in 0.1-0.2% of cases. Awakening during a surgical procedure may result in significant psychological complications (e.g. post-traumatic stress disorder), and the patient may suffer from a serious long-time disorder.


Description:

In order to prevent, or minimize the perioperative awareness, it is possible to utilize two different methods of depth of anaesthesia monitoring. The options may be divided into two basic groups: A/ The use of clinical monitoring and other methods (apart from CNS), and B/ Methods based on monitoring of the electrical activity of the brain. In the first group, it is possible to list the following options: 1. clinical assessment (Evans's score), 2. skin conductance, 3. isolated method of measurement at the forearm, 4. spontaneous superficial electromyogram (SEMG), 5. lower oesophageal contractility, and 6. various hearth rate. The possibilities of depth of GA monitoring using the scanning of electrical brain activity may be further subdivided into two groups: a/ methods based on EEG, and b/ methods assessing evoked potentials. In the group of methods based on EEG, the following devices may be used to monitor the depth of GA in practice:

a/ BIS monitor, b/ E-Entropy, c/ Narcotrend, and d/ SedLine Sedation Monitor. In the second group using evoked potentials it is possible to utilize monitors measuring electrical activity in certain areas of the brain, in relation to stimulation of specific sensory nerve pathways: a/ somatosensory, b/ visual, and c/ auditive evoked potentials.

Aims of the Study:

Null hypothesis: The use of depth of general anaesthesia monitoring in children in the course of a surgical procedure does not affect the number of post-operative complications related to the depth of GA, does not shorten the period of emergence from GA, does not decrease the amount of inhalation anaesthetics used, and does not decrease the amount of opioids used.

Primary aim: To test, whether the administration of anaesthesia in children in the course of a surgical procedure with the depth of general anaesthesia monitoring with the BIS monitor results in a decrease in the number of complications related to inappropriate depth of GA.

Secondary aim: To verify, whether the administration of anaesthesia in children in the course of a surgical procedure with the depth of general anaesthesia monitoring with the BIS monitor:

1. results in a shortening of the emergence from general anaesthesia

2. results in a decrease in the amount of inhalation anaesthetic used

3. results in a decrease in the amount of analgesics used

Tertiary aim: To verify, whether the administration of general anaesthesia in children in the course of a surgical procedure with the depth of general anaesthesia monitoring with the BIS monitor:

a/results in a decrease of early post-operative complications at the recovery room.

Study design:

Procedure to achieve the study aims The study is a prospective, interventional study, performed at the Anaesthesiology-Resuscitation Department of the University Hospital Ostrava. The study has been approved by the Head of the Department, prof. Pavel Ševčík, MD, CSc. Furthermore, the study has been approved by the Ethics Committee of the University Hospital Ostrava and is in compliance with the principles of the Declaration of Helsinki. Informed consent will be obtained for every paediatric patient, the Informed consent form has also been approved by the Ethics Committee, and will be signed by both parents.

The study group will include paediatric patients at the age from 28 days to 15 years of age (including), ASA I classification.

Interventional arm of the study will be characterized by the BIS monitoring and management of the hypnotic component of general anaesthesia towards the values of BIS 40-60.

Conventional arm of the study will be performed without the depth of anaesthesia monitoring (however, the BIS value will be recorded by an independent participant), and management of the hypnotic component of general anaesthesia according to MAC value appropriate for the age of the child.

Each study arm will include the total of 100 paediatric study subjects. Randomization will be performed by the envelope method.

Definition of terms

- BIS group: group of patients, in whom the hypnotic component of GA will be managed towards the value of BIS 40-60.

- Non-BIS group: group of patients, in whom the hypnotic component of GA will be managed towards the MAC value appropriate for the age of the child. Depth of GA will be also monitored with the BIS monitor, however, the BIS value will be unknown to the investigator.

- Period of emergence from anaesthesia: time interval from the moment of setting the zero concentration of inhalation anaesthetics on the vaporizer to the moment when the child manifests the signs of complete awareness: spontaneous ventilation, spontaneous motility, rising of the head, clasping of the hand, or crying.

- Consumption of inhalation anaesthetic: consumption of inhalation anaesthetic will be measured in two follow-up time phases of GA:

1. Phase 1: from the moment when administration of the inhalation anaesthetic is initiated to the moment when breathing passageways are secured (LM, OTI). This phase of GA is characterized with a higher concentration of the inhalation anaesthetic and standard flows: O2, AIR in proportion of 2:2 l/min,

2. Phase 2: continues after Phase 1, from the moment when breathing passageways are secured to the moment, when the zero value is set on the vaporizer. This phase of GA is characterized with gas flows: O2, AIR in proportion of 0.5:0.5 l/min.

- Consumption of analgesics: the amount of analgesics used during GA

- Early post-operative complications (assessed in the recovery room): the need of re-intubation, need to apply antidotes, laryngospasm, bronchospasm, hyperalgesia (pain assessment according to standard scales), vomiting

- Emergence from GA (Phase 3): continues after Phase 2, from the moment when the zero value is set on the vaporizer to the moment of LM or intubation cannula removal.

5.2.2. Protocol of GA management in the "BIS group": BIS monitor will be used during the GA monitoring, the BIS value will be known to the anaesthetist (investigator)

- GA induction (Phase 1):

1. inhalation introduction (Sevorane, 02,AIR (flow 2:2 l/min)) or

2. intra-venous introduction: (Suphentanil: (0.1-0.3 ug/kg iv.), Propofol (2-2,5 mg/kg iv.), or Mivacron (0.15-2mg/kg ),Tracrium (0.3-0.6mg/kg)

- anaesthesia (Phase 2, Phase 3):

1. hypnotic component: titration of Sevorane concentration, with the aim of achieving the BIS values of 40-60%, bearing gas mixture: O2/AIR (in proportion of 1:1, with 0.5:0.5 flows)

2. analgesic component: Suphentanil (continuous dose of 0.1-0.3ug/kg iv. every 20-30 min)

3. relaxation: Mivacron (continuous dose of 0.1mg/kg iv.), Tracrium(0.3-0.6 mg/kg) 5.2.3. Protocol of GA management in the "Non-BIS group" BIS monitor will be used during the GA monitoring, however the BIS value will not be known to the anaesthetist (investigator)

- GA induction (Phase 1):

1. inhalation introduction (Sevorane, 02,AIR (flow 2:2 l/min)) or

2. intra-venous introduction: (Suphentanil: (0.1-0.3 ug/kg iv.), Propofol (2-2,5 mg/kg iv.), or Mivacron (0.15-2mg/kg ),Tracrium (0.3-0.6mg/kg)

- anaesthesia (Phase 2, Phase 3):

1. hypnotic component: titration of Sevorane concentration, with the aim of achieving the MAC value appropriate for the age of the child, bearing gas mixture: O2/AIR (in proportion of 1:1, with 0.5:0.5 flows)

2. analgesic component: Suphentanil (continuous dose of 0.1-0.3ug/kg iv. every 20-30 min)

3. relaxation: Mivacron (continuous dose of 0.1mg/kg iv.), Tracrium(0.3-0.6 mg/kg)

Assessment:

The following parameters will be observed in the "BIS group" and the "Non-BIS group":

- occurrence of perioperative complications

- period of emergence from GA

- consumption of opioids

- consumption of inhalation anaesthetic

- occurrence of early post-operative complications at the recovery room

- BIS value

Statistical processing:

The obtained statistical data will be processed using statistical methods and presented in the form of tables and charts.


Recruitment information / eligibility

Status Completed
Enrollment 220
Est. completion date November 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group N/A to 15 Years
Eligibility Inclusion Criteria:

- appropriate age

- informed consent form signed by both parents (according to national legislation)

- need to undergo a procedure in general anaesthesia

- ASA I classification

Exclusion Criteria:

- non-signing of the informed consent form by both parents

- ASA classification higher than I

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
BIS Group
BIS monitoring will be used in the BIS Group patients. The BIS value will be known to the anaesthetist, who will be able to act accordingly.
Non-BIS Group
BIS monitoring will be used in the Non-BIS Group patients. The BIS value will NOT be known to the anaesthetist and will be observed by a trained co-investigator, with subsequent evaluation.
Drug:
Anaesthetics
Anaesthetics will be administered in both experimental groups, in order to maintain the required general anaesthesia.

Locations

Country Name City State
Czechia University Hospital Ostrava Ostrava Moravian-Silesian Region

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Ostrava

Country where clinical trial is conducted

Czechia, 

Outcome

Type Measure Description Time frame Safety issue
Other Decrease of complications at recovery room The decrease in complications at recovery room will be measured and compared in both groups. 24 months
Primary Occurrence of perioperative complications The occurrence of perioperative complications due to inappropriate depth of general anaesthesia will be observed. 24 months
Secondary Shortening of the emergence from general anaesthesia The time of emergence from general anaesthesia will be measured and compared in both groups. 24 months
Secondary Decrease in the amount of inhalation anaesthetic used The decrease in the amount of inhalation anaesthetic used will be measured and compared in both groups. 24 months
Secondary Decrease in the amount of analgesics used The decrease in the amount of analgesics used will be measured and compared in both groups. 24 months
See also
  Status Clinical Trial Phase
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Completed NCT02920749 - Study of Anaesthesia Costs and Recovery Profiles N/A
Active, not recruiting NCT02184780 - Impact of Perinatal Anaesthesia and Analgesia on Neurocognitive Outcomes in Early Childhood
Completed NCT02025153 - Comprehensive Pain Programme to Determine Mechanism of Transition of Acute to Chronic Postsurgical Pain N/A
Completed NCT02265822 - Melatonin Premedication in Children Undergoing Surgery Phase 4
Completed NCT01457274 - "Light" Versus "Deep" Bispectral Index (BIS) Guided Sedation for Colonoscopy N/A
Completed NCT00521612 - Sevoflurane vs. Isoflurane for Low-Flow General Anaesthesia for Abdominal Surgery N/A
Completed NCT00455117 - Effect of Parecoxib on Post-craniotomy Pain Phase 4
Completed NCT02150460 - A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at Kaduna, Nigeria Phase 4
Completed NCT01041352 - Laryngeal Mask or Endotracheal Tube for Back Surgery in the Prone Position N/A
Terminated NCT02801799 - Effects of Local Anaesthetic Infusion Rates on Nerve Block Duration Phase 1
Completed NCT02923427 - I-gel vs LMA Supreme in Laparoscopic Gynecological Surgery N/A
Completed NCT01971996 - Measuring the Effect of External Pressure on the Regional Cerebral Oxygen Saturation Monitored by Near-infrared Spectroscopy(NIRS) Technology N/A
Completed NCT01076790 - Dexmedetomidine-propofol-remifentanil Anaesthesia and Reactivity to Noxious Stimuli Phase 4
Completed NCT01022151 - Aminophylline and Cognitive Function After Sevoflurane Anaesthesia Phase 2
Completed NCT02442609 - Internet for Anesthesia Information : a Patient Questionaire N/A
Recruiting NCT02125838 - Laryngeal Mask Supreme During Laparoscopic Gynecologic Surgery Phase 4
Completed NCT01780571 - CPAP/PSV Preoxygenation in Obese Patients N/A
Completed NCT03380715 - A Comparison Between Co-phenylcaine Nasal Spray and Nasal Nebulization Prior to Rigid Nasoendoscopic Examination N/A
Recruiting NCT04070404 - Quality of Preoxygenation in Emergency Surgery